| Cross-cohort analysis identifies a TEAD4–MYCN positive feedback loop as the core regulatory element of high-risk neuroblastoma P Rajbhandari, G Lopez, C Capdevila, B Salvatori, J Yu, ... Cancer discovery 8 (5), 582-599, 2018 | 146 | 2018 |
| RETRACTED ARTICLE: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs M Yarmarkovich, QF Marshall, JM Warrington, R Premaratne, A Farrel, ... Nature 599 (7885), 477-484, 2021 | 100 | 2021 |
| Identification of SARS-CoV-2 vaccine epitopes predicted to induce long-term population-scale immunity M Yarmarkovich, JM Warrington, A Farrel, JM Maris Cell Reports Medicine 1 (3), 2020 | 82 | 2020 |
| Anomalous uptake and circulatory characteristics of the plant-based small RNA MIR2911 J Yang, T Hotz, LC Broadnax, M Yarmarkovich, I Elbaz-Younes, ... Scientific reports 6 (1), 26834, 2016 | 72 | 2016 |
| Influence of glycosylation pattern on the molecular properties of monoclonal antibodies K Zheng, M Yarmarkovich, C Bantog, R Bayer, TW Patapoff MAbs 6 (3), 649-658, 2014 | 66 | 2014 |
| High throughput pMHC-I tetramer library production using chaperone-mediated peptide exchange SA Overall, JS Toor, S Hao, M Yarmarkovich, SM O’Rourke, GI Morozov, ... Nature communications 11 (1), 1909, 2020 | 51 | 2020 |
| A recurrent mutation in anaplastic lymphoma kinase with distinct neoepitope conformations JS Toor, AA Rao, AC McShan, M Yarmarkovich, S Nerli, K Yamaguchi, ... Frontiers in Immunology 9, 99, 2018 | 34 | 2018 |
| Immunogenicity and immune silence in human cancer M Yarmarkovich, A Farrel, A Sison III, M Di Marco, P Raman, JL Parris, ... Frontiers in immunology 11, 69, 2020 | 31 | 2020 |
| Targeting of intracellular oncoproteins with peptide-centric CARs M Yarmarkovich, QF Marshall, JM Warrington, R Premaratne, A Farrel, ... Nature 623 (7988), 820-827, 2023 | 26 | 2023 |
| When cold is hot: immune checkpoint inhibition therapy for rhabdoid tumors M Yarmarkovich, JM Maris Cancer Cell 36 (6), 575-576, 2019 | 13 | 2019 |
| Digesting dietary miRNA therapeutics M Yarmarkovich, KD Hirschi Oncotarget 6 (16), 13848, 2015 | 8 | 2015 |
| Structural principles of peptide-centric chimeric antigen receptor recognition guide therapeutic expansion Y Sun, TJ Florio, S Gupta, MC Young, QF Marshall, SE Garfinkle, ... Science immunology 8 (90), eadj5792, 2023 | 4 | 2023 |
| Pulse Transit Time Measuring Device JBT Leader, K Chen–BSAC, W Stanford–BWIG, ... BME 200, 300, 2006 | 3 | 2006 |
| Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma. Cancer discovery, 8 (5): 582–599, may 2018. ISSN … P Rajbhandari, G Lopez, C Capdevila, B Salvatori, J Yu, ... CD-16-0861, 0 | 3 | |
| A SARS-CoV-2 vaccination strategy focused on population-scale immunity M Yarmarkovich, JM Warrington, A Farrel, JM Maris Social Science Research Network, 2020 | 2 | 2020 |
| CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastoma G Pascual-Pasto, B McIntyre, MG Hines, AM Giudice, L Garcia-Gerique, ... Nature Communications 15 (1), 7141, 2024 | 1 | 2024 |
| Abstract PO-049: SARS-CoV-2 multiepitope vaccine constructs designed to drive long-term immunity in the majority of the population M Yarmarkovich, JM Warrington, A Farrel, JM Maris Clinical Cancer Research 26 (18_Supplement), PO-049-PO-049, 2020 | 1 | 2020 |
| SARS-CoV-2 multiepitope vaccine constructs designed to drive long-term immunity in the majority of the population. M Yarmarkovich, JM Warrington, A Farrel, JM Maris CLINICAL CANCER RESEARCH 26 (18), 2020 | 1 | 2020 |
| MHC class I immunogenicity and novel tumor antigen discovery in neuroblastoma M Yarmarkovich, MD Marco, O Padovan, J Lobby, L Eisenlohr, D Monos, ... Cancer Research 77 (13_Supplement), 5824-5824, 2017 | 1 | 2017 |
| Quantifying tumor specificity using Bayesian probabilistic modeling for drug and immunotherapeutic target discovery G Li, D Schnell, A Bhattacharjee, M Yarmarkovich, N Salomonis Cell Reports Methods, 2024 | | 2024 |